MDGL

MADRIGAL PHARMACEUTICALS INC

Healthcare | Large Cap

-$0.85

EPS Forecast

$408.4

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-12-31

Proximilar's AI forecasts

EPS Forecast:

-$0.85

Revenue Forecast:

$408.4

EPS Surprise Forecast:

$0.234

Revenue Surprise Forecast:

$8

Post-release price volatility - High

Post-release Overnight Move:

±9.6%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

69%

Probability of beating revenue consensus:

73%

Probability of beating both EPS & revs consensus:

56%

Probability of missing both EPS & revs consensus:

14%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-2

Beta (β)

Forward Looking Beta (β):

0.33

Earnings volatility

EPS standard deviation:

$1.25

Revenue standard deviation:

$29

As % of share price:

0.26% MEDIUM

As % of market cap:

0.26% LOW

Confidence intervals and percentiles

EPS 95th %ile:

$0.86

Revenue 95th %ile:

$449

EPS 75th %ile:

-$0.40

Revenue 75th %ile:

$419

EPS 25th %ile:

-$1.19

Revenue 25th %ile:

$399

EPS 5th %ile:

-$2.13

Revenue 5th %ile:

$375

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

45% HIGH

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

44% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$34

Bid-ask per Share:

$1.6